Some authors have observed a loss of SST2 expression in more advanced stages of some CRC cases, or even in tumors of patients with higher CEA level, as compared with control or with patients with lower CEA levels, which could be associated with a loss of cellular regulation and subsequent excessive proliferation [117,138,166]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.